Who to call at AbbVie Inc., and when
Fundz watches for the moments AbbVie Inc. starts buying, and tells you who to reach.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1.
Contract Type
partnership
North ChicagoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaDescription
AbbVie has announced a partnership with McLaren Racing, becoming an official pharmaceutical partner of the McLaren Mastercard F1 Team. This collaboration aims to draw parallels between AbbVie’s work in immunology and the Formula 1 teams, while also promoting health awareness.
Quick answer
AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026). AbbVie Inc. is based in North Chicago, Illinois, United States.
- What agreement did AbbVie Inc. announce on November 3, 2026?
- AbbVie has announced a partnership with McLaren Racing, becoming an official pharmaceutical partner of the McLaren Mastercard F1 Team. This collaboration aims to draw parallels between AbbVie’s work in immunology and the Formula 1 teams, while also promoting health awareness.
- What does AbbVie Inc. do?
- Venture capital subsidiary of Abbvie
- Where is AbbVie Inc. based?
- AbbVie Inc. is based in North Chicago, Illinois, United States.
- Which similar companies announced agreements around the same time?
- Teva Pharmaceutical Industries Ltd (November 3, 2026), Celltrion (October 26, 2026), Aarvik Therapeutics (November 3, 2026) and Alexion (October 29, 2026) also announced agreements within 45 days of AbbVie Inc.
Source: Fundz verified event record.
Other recent agreements in Healthcare and Therapeutics
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- Celltrion Secures Exclusive Supply Agreement for Omlyclo and Aptozma with U.S. Healthcare Company to Expand Market Access. (October 26, 2026)
- Aarvik Therapeutics Enters Partnership with Laurus Labs for MUTTA™ ADC Development in India. (November 3, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- Edesa Biotech Enters Collaboration and License Agreement with Kyorin Pharmaceutical (November 9, 2026)
- Ocugen Enters Exclusive License Agreement with Celairis Therapeutics (November 10, 2026)
Related People
Agreement Insights
What this usually meansAbbVie Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.